• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ALINITY I HAVAB-IGG REAGENT KIT; HEPATITIS A TEST (ANTIBODY AND IGM ANTIBODY)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ALINITY I HAVAB-IGG REAGENT KIT; HEPATITIS A TEST (ANTIBODY AND IGM ANTIBODY) Back to Search Results
Catalog Number 08P26-22
Device Problem False Positive Result (1227)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 12/01/2020
Event Type  malfunction  
Manufacturer Narrative
This report is being filed on an international product list 8p26, that has a similar us product distributed in the us, list 8p27.An evaluation is in process.A followup report will be submitted when the evaluation is complete.
 
Event Description
The account observed false reactive alinity i havab igg values between 1 to 2 s/co on samples that repeat reactive but when a new sample is obtained a negative result is generated.The patients are hiv positive that come to the lab for routine vaccination.No specific patient information was provided.No impact to patient management was reported.
 
Manufacturer Narrative
The complaint evaluation included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review and testing of in house retained kits with the complaint lot number.The ticket search by lot indicates that the reagent lot performs as expected for this product.Trending review determined no adverse trend for the issue for the product.Labeling review concludes that the issue is adequately addressed.Device history record review did not identify any non-conformances or deviations with the complaint lot and complaint issue.Results of in house testing of a retained kit showed that, all specifications were met and no false reactive results were obtained, indicating that the specificity performance is not negatively impacted.Based on the evaluation, no systemic issue or product deficiency with the alinity i havab igg reagent lot was identified in the complaint.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I HAVAB-IGG REAGENT KIT
Type of Device
HEPATITIS A TEST (ANTIBODY AND IGM ANTIBODY)
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key11071926
MDR Text Key223608187
Report Number3002809144-2020-01208
Device Sequence Number1
Product Code LOL
Combination Product (y/n)N
PMA/PMN Number
K113704
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 02/03/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/24/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/29/2021
Device Catalogue Number08P26-22
Device Lot Number16126BE00
Was Device Available for Evaluation? No
Date Manufacturer Received01/11/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALNTY I PROCESSING MODU, 03R65-01, AI01890; ALNTY I PROCESSING MODU, 03R65-01, AI01890; ALNTY I PROCESSING MODU, 03R65-01, AI01890
-
-